MA51873A - Molécules probiotiques pour réduire la virulence d'agents pathogènes - Google Patents
Molécules probiotiques pour réduire la virulence d'agents pathogènesInfo
- Publication number
- MA51873A MA51873A MA051873A MA51873A MA51873A MA 51873 A MA51873 A MA 51873A MA 051873 A MA051873 A MA 051873A MA 51873 A MA51873 A MA 51873A MA 51873 A MA51873 A MA 51873A
- Authority
- MA
- Morocco
- Prior art keywords
- virulence
- reduce
- pathogenic agents
- probiotic molecules
- probiotic
- Prior art date
Links
- 239000003795 chemical substances by application Substances 0.000 title 1
- 230000001717 pathogenic effect Effects 0.000 title 1
- 239000006041 probiotic Substances 0.000 title 1
- 230000000529 probiotic effect Effects 0.000 title 1
- 235000018291 probiotics Nutrition 0.000 title 1
- 230000001018 virulence Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/195—Proteins from microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Immunology (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762472061P | 2017-03-16 | 2017-03-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA51873A true MA51873A (fr) | 2020-01-22 |
Family
ID=63521745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA051873A MA51873A (fr) | 2017-03-16 | 2018-03-16 | Molécules probiotiques pour réduire la virulence d'agents pathogènes |
Country Status (16)
Country | Link |
---|---|
US (2) | US11912788B2 (fr) |
EP (1) | EP3595698A4 (fr) |
JP (2) | JP2020510096A (fr) |
KR (2) | KR20240046640A (fr) |
CN (1) | CN110621332A (fr) |
AU (2) | AU2018233183A1 (fr) |
BR (1) | BR112019019256A2 (fr) |
CA (1) | CA3056719A1 (fr) |
CL (1) | CL2019002640A1 (fr) |
EA (1) | EA201992176A1 (fr) |
MA (1) | MA51873A (fr) |
MX (1) | MX2019011058A (fr) |
PE (1) | PE20191783A1 (fr) |
PH (1) | PH12019502340A1 (fr) |
SG (1) | SG11201909606RA (fr) |
WO (1) | WO2018165765A1 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020510096A (ja) | 2017-03-16 | 2020-04-02 | マイクロシンテシス インコーポレイテッド | 病原体の毒性を低減するためのプロバイオティクス分子 |
BR112019019255A2 (pt) * | 2017-03-16 | 2020-04-14 | Microsintesis Inc | composições e métodos envolvendo moléculas probióticas |
CN114786703A (zh) * | 2019-07-02 | 2022-07-22 | 微合成有限公司 | 群体感应抑制剂和/或后生元代谢物及相关方法 |
CN115039885B (zh) * | 2021-05-14 | 2023-11-03 | 江苏艾兰得营养品有限公司 | 一种具有抑制奇异变形杆菌生长作用的副干酪乳杆菌及其益生菌组合物、发酵液和应用 |
GB2613406A (en) * | 2021-05-14 | 2023-06-07 | Ivc Nutrition Corp | Probiotic having effect of inhibiting growth of proteus mirabilis, and fermentation broth and use thereof |
KR102337951B1 (ko) * | 2021-06-25 | 2021-12-13 | 주식회사 비피도 | 요로감염 개선, 예방 또는 치료를 위한 락토바실러스 헬베티쿠스 gut10 균주 및 이를 포함하는 조성물 |
KR102356423B1 (ko) * | 2021-07-02 | 2022-02-09 | (주)에스디생명공학 | 항균, 피부 보습, 항아토피, 피부 장벽 강화, 및 주름 개선 활성을 갖는 복합 균주를 유효성분으로 포함하는 조성물 |
KR102618322B1 (ko) * | 2021-10-08 | 2023-12-27 | 순천향대학교 산학협력단 | 신규한 락토 바실러스 균주, 및 이를 포함하는 결핵 예방, 치료, 또는 개선용 조성물 |
CN114106096A (zh) * | 2021-11-16 | 2022-03-01 | 华南理工大学 | 一种具有改善睡眠活性的六肽及其应用 |
CN114591879B (zh) * | 2022-05-11 | 2022-12-06 | 中国农业大学 | 一种抑制幽门螺杆菌的发酵乳杆菌及其应用 |
KR102551065B1 (ko) * | 2022-05-12 | 2023-07-03 | 중앙대학교 산학협력단 | 김치로부터 유래된 LAB(lactic acid bacteria)을 유효성분으로 포함하는 항-바이오필름 조성물 |
CN116478882A (zh) * | 2023-05-05 | 2023-07-25 | 石河子大学 | 能够提高绵羊日增重和饲料转化率的产酸的混合菌制剂的制备方法 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0395309B1 (fr) | 1989-04-28 | 1995-12-27 | Takara Shuzo Co. Ltd. | Polypeptide semblable à la calpastatine humaine |
FR2686085B1 (fr) | 1992-01-10 | 1995-08-04 | Agronomique Inst Nat Rech | Peptides representant des fragments du cmp, anticorps diriges contre lesdits peptides, et leurs utilisations. |
WO1994018832A1 (fr) | 1993-02-26 | 1994-09-01 | Dana-Farber Cancer Institute, Inc. | Modulation a mediation cd4 de kinases lipidiques |
US7393663B2 (en) | 1997-08-01 | 2008-07-01 | Serono Genetics Institute S.A. | Expressed sequence tags and encoded human proteins |
US20040031072A1 (en) | 1999-05-06 | 2004-02-12 | La Rosa Thomas J. | Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement |
WO2004092206A1 (fr) * | 2003-04-14 | 2004-10-28 | Meiji Dairies Corporation | Peptide, immunopotentiateur et nourriture fonctionnelle ; procede de fabrication de la nourriture fonctionnelle |
DE10317870A1 (de) * | 2003-04-17 | 2004-11-04 | Crompton Vinyl Additives Gmbh | Neues Stabilisatorsystem zur Stabilisierung von halogenhaltigen Polymeren |
EP1706126A4 (fr) * | 2003-12-04 | 2009-07-01 | Biofilms Strategies Inc | Procedes et compositions pour la prevention de formation de biofilms, la reduction de biofilms existants, et pour la reduction des populations de bacteries |
US7306677B2 (en) * | 2004-01-30 | 2007-12-11 | Boston Scientific Corporation | Clamping fixture for coating stents, system using the fixture, and method of using the fixture |
JP5068174B2 (ja) | 2004-12-23 | 2012-11-07 | カンピナ ネーデルランド ホールディング ビー.ブイ. | Dpp−ivを阻害するペプチド中に濃縮されたタンパク質の加水分解物及びその使用 |
WO2007057872A2 (fr) | 2005-11-21 | 2007-05-24 | Teagasc-National Diary Products Research Centre | Peptides antimicrobiens et souches bactériennes les produisant |
US8431528B2 (en) | 2008-05-16 | 2013-04-30 | University Of Maryland, Baltimore | Antibacterial Lactobacillus GG peptides and methods of use |
US20110262400A1 (en) * | 2008-06-27 | 2011-10-27 | University Of Guelph | Probiotic bacterial molecules and their use in methods to treat/prevent infection by harmful bacteria and to provide nutritional health |
EP2550529B1 (fr) | 2010-03-23 | 2021-11-17 | Iogenetics, LLC. | Procédés bioinformatiques pour déterminer la liaison de peptides |
PT105073A (pt) | 2010-04-26 | 2011-10-26 | Consejo Superior Investigacion | Processo de obtenção de extractos peptídicos bioactivos através da hidrólise de proteínas de soro de leite com enzimas de cynara cardunculus, referidos extractos e respectivas utilizações |
WO2014020209A1 (fr) * | 2012-07-30 | 2014-02-06 | Consejo Superior De Investigaciones Científicas (Csic) | Utilisation d'hydrolysats de protéines lactées comme protecteurs au niveau gastro-intestinal |
US9273096B2 (en) * | 2012-08-29 | 2016-03-01 | Agency For Science, Technology And Research | Amphiphilic peptides comprising the formula I: (X1Y1X2Y2)n, and uses thereof |
US9637523B2 (en) | 2012-08-31 | 2017-05-02 | Westfaelische Wilhelms-Universitaet Muenster | Methods and peptides for preventing and treating a BCR-ABL and a C-ABL associated disease |
US9861666B2 (en) | 2013-08-12 | 2018-01-09 | Mansel Griffiths | Antiviral methods and compositions comprising probiotic bacterial molecules |
ES2757563T3 (es) * | 2013-10-31 | 2020-04-29 | Hutchison Biofilm Medical Solutions Ltd | Uso de péptidos en resistencia a antibióticos |
CA3172682A1 (fr) | 2015-04-23 | 2016-10-27 | Nantomics, Llc | Neo-epitopes de cance |
JP2020510096A (ja) | 2017-03-16 | 2020-04-02 | マイクロシンテシス インコーポレイテッド | 病原体の毒性を低減するためのプロバイオティクス分子 |
BR112019019255A2 (pt) | 2017-03-16 | 2020-04-14 | Microsintesis Inc | composições e métodos envolvendo moléculas probióticas |
-
2018
- 2018-03-16 JP JP2019572266A patent/JP2020510096A/ja active Pending
- 2018-03-16 EP EP18766973.4A patent/EP3595698A4/fr active Pending
- 2018-03-16 EA EA201992176A patent/EA201992176A1/ru unknown
- 2018-03-16 KR KR1020247010732A patent/KR20240046640A/ko not_active Application Discontinuation
- 2018-03-16 BR BR112019019256A patent/BR112019019256A2/pt unknown
- 2018-03-16 WO PCT/CA2018/050320 patent/WO2018165765A1/fr unknown
- 2018-03-16 CA CA3056719A patent/CA3056719A1/fr active Pending
- 2018-03-16 MA MA051873A patent/MA51873A/fr unknown
- 2018-03-16 MX MX2019011058A patent/MX2019011058A/es unknown
- 2018-03-16 AU AU2018233183A patent/AU2018233183A1/en not_active Abandoned
- 2018-03-16 CN CN201880031802.5A patent/CN110621332A/zh active Pending
- 2018-03-16 SG SG11201909606R patent/SG11201909606RA/en unknown
- 2018-03-16 PE PE2019001882A patent/PE20191783A1/es unknown
- 2018-03-16 US US16/494,429 patent/US11912788B2/en active Active
- 2018-03-16 KR KR1020197030393A patent/KR20190140443A/ko not_active IP Right Cessation
-
2019
- 2019-09-16 CL CL2019002640A patent/CL2019002640A1/es unknown
- 2019-10-14 PH PH12019502340A patent/PH12019502340A1/en unknown
-
2022
- 2022-05-30 AU AU2022203650A patent/AU2022203650B2/en active Active
-
2023
- 2023-01-05 JP JP2023000419A patent/JP2023036938A/ja active Pending
-
2024
- 2024-01-15 US US18/412,769 patent/US20240150399A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3595698A4 (fr) | 2020-12-23 |
PH12019502340A1 (en) | 2020-10-19 |
JP2023036938A (ja) | 2023-03-14 |
US20200017547A1 (en) | 2020-01-16 |
US20240150399A1 (en) | 2024-05-09 |
JP2020510096A (ja) | 2020-04-02 |
CA3056719A1 (fr) | 2018-09-20 |
KR20190140443A (ko) | 2019-12-19 |
WO2018165765A9 (fr) | 2018-11-22 |
US11912788B2 (en) | 2024-02-27 |
EP3595698A1 (fr) | 2020-01-22 |
AU2022203650B2 (en) | 2024-04-11 |
AU2018233183A1 (en) | 2019-10-31 |
AU2022203650A1 (en) | 2022-06-16 |
BR112019019256A2 (pt) | 2020-04-14 |
PE20191783A1 (es) | 2019-12-24 |
CN110621332A (zh) | 2019-12-27 |
KR20240046640A (ko) | 2024-04-09 |
SG11201909606RA (en) | 2019-11-28 |
WO2018165765A1 (fr) | 2018-09-20 |
MX2019011058A (es) | 2019-12-09 |
EA201992176A1 (ru) | 2020-03-04 |
CL2019002640A1 (es) | 2020-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA51873A (fr) | Molécules probiotiques pour réduire la virulence d'agents pathogènes | |
MA45539A (fr) | Dihydropyranopyrimidines pour le traitement d'infections virales | |
MA44083A (fr) | Composés de biarylmonobactame pour le traitement d'infections bactériennes | |
MA44486A (fr) | Procédés d'intervention précoce pour prévenir ou atténuer la toxicité | |
ITUA20161821A1 (it) | Sensori ultrasonici per misurare l'irregolarita' del terreno | |
FR24C1017I1 (fr) | Utilisations d'antagonistes d'il-13 pour le traitement de la dermatite atopique | |
MA43811A (fr) | Composés d'arylmonobactame bicycliques et leurs méthodes d'utilisation pour le traitement des infections bactériennes | |
MA51056A (fr) | Compositions et méthodes pour le traitement d'affections métaboliques | |
MA49576A (fr) | Compositions et méthodes pour le traitement d'infections fongiques | |
FR3022462B1 (fr) | Composition orale d'anticorps anti-tnfalpha | |
MA45552A (fr) | Compositions destinées au traitement de l'amylose | |
MA51795A (fr) | Oligonucléotides pour moduler l'expression de tmem106b | |
FR3020758B1 (fr) | Composition pour ameliorer l'hygiene buco-dentaire | |
MA46431A (fr) | Composés et procédés pour réduire l'expression de tau | |
MA45327A (fr) | Utilisation de probiotiques pour améliorer l'absorption des protéines | |
MA43051A (fr) | Polythérapie pour le traitement d'une du vhc | |
MA50163A (fr) | Compositions, utilisations et méthodes pour le traitement de l'infertilité et de la sous-fertilité | |
MA43764A (fr) | Inhibiteur monovalent de l'interaction hutnfr1 | |
IT201700085409A1 (it) | Composizione per il trattamento di infezioni causate da agenti patogeni | |
MA45492A (fr) | Vecteurs viraux pour le traitement de l'hyperactivité vésicale neurogène | |
FR3023472B1 (fr) | Ensemble pour l'arthroplastie du pied | |
TH188028B (th) | กระเป๋า | |
TH184653B (th) | ขวด | |
MA50120A (fr) | Méthodes de traitement à l'aide d'un promédicament d'amphétamine | |
TH164464B (th) | อ่างล้างหน้า |